Table 1. Assay validation precision and accuracy.
Biomarker | Nominal Concentration (pg/mL) | Mean Measured Concentration (pg/mL) |
% CV | % Theoretical |
---|---|---|---|---|
IL-6 | 2.45 (LLOQ) | 2.58 | 1.0 | 105.3 |
7.72 | 7.38 | 3.3 | 95.6 | |
54.50 | 54.30 | 3.2 | 99.6 | |
265 | 263 | 0.9 | 99.2 | |
444 (ULOQ) | 476 | 2.2 | 107.2 | |
CRP | 69.2 (LLOQ) | 67.7 | 1.4 | 97.8 |
6440 | 6073 | 0.5 | 94.3 | |
1940 | 17907 | 1.2 | 92.3 | |
68000 | 71871 | 0.2 | 105.7 | |
108000 (ULOQ) | 131880 | 4.0 | 122.1 | |
TNFα | 0.79 (LLOQ) | 0.87 | 3.0 | 113.5 |
2.17 | 2.08 | 4.2 | 95.9 | |
16.4 | 14.8 | 1.4 | 90.2 | |
95.5 | 85.7 | 2.9 | 89.7 | |
211 (ULOQ) | 211 | 2.5 | 100.0 | |
MCP-1 | 8.28 (LLOQ) | 8.67 | 1.8 | 104.8 |
11.9 | 11.0 | 9.8 | 92.4 | |
69.2 | 63.5 | 5.5 | 91.8 | |
438 | 430 | 3.2 | 98.2 | |
1060 (ULOQ) | 1080 | 4.3 | 99.5 | |
MIP-1β | 17.5 (LLOQ) | 24.5 | 7.8 | 90.4 |
142 | 132.0 | 4.6 | 93.0 | |
560 | 544.5 | 1.9 | 97.2 | |
776 | 745 | 1.3 | 96.0 | |
2240 (ULOQ) | 2330 | 0.4 | 104.0 | |
Eotaxin | 56.8 (LLOQ) | 57.4 | 4.8 | 101.0 |
180 | 168.0 | 2.3 | 93.3 | |
553 | 520 | 4.5 | 94 | |
1480 | 1410 | 2.2 | 95.3 | |
3640 (ULOQ) | 3775 | 8.6 | 103.7 | |
VCAM-1 | 90.8 (LLOQ) | 89.1 | 1.0 | 98.1 |
1690 | 1536 | 0.6 | 90.9 | |
5110 | 4786 | 0.9 | 93.7 | |
17900 | 16826 | 1.8 | 94.1 | |
28400 (ULOQ) | 28201 | 5.1 | 99.3 |
CV; coefficient of variance; LLOQ; lower limit of quantification, ULOQ; upper limit of quantification